Roche records 4% decline in H1 2024 net income
Roche has reported a net income of SFr6.6bn ($7.4bn) in the first half (H1) of 2024, marking a 4% decline…
Roche has reported a net income of SFr6.6bn ($7.4bn) in the first half (H1) of 2024, marking a 4% decline…
Mankind Pharma has announced a definitive agreement for the acquisition of a 100% stake in Bharat Serums and Vaccines (BSV)…
AbbVie has announced its financial results for the second quarter (Q2) of 2024, revealing a 32.1% decrease in net earnings…
The European Commission (EC) has awarded conditional marketing authorisation for Pfizer's DURVEQTIX (fidanacogene elaparvovec), a one-time gene therapy for use…
The US Food and Drug Administration (FDA) has expanded its approval of BioMarin Pharmaceutical's supplemental biologics licence application (sBLA) for…
The UK National Institute for Health and Care Excellence (NICE) has issued final guidance endorsing Boehringer Ingelheim’s tenecteplase, marketed as…
Dren Bio has partnered strategically with Novartis subsidiary Novartis Pharma to discover and develop therapeutic bispecific antibodies to treat cancer.…
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorised the use of Pfizer-BioNTech’s adapted Comirnaty vaccine to combat…
BioNTech and Triastek have entered a research partnership and platform technology licence agreement focusing on the development of 3D-printed oral…
BeiGene has announced the opening of its new US biologics manufacturing and clinical research and development (R&D) facility at Hopewell,…